Non-alcoholic fatty liver disease proteomics

Proteomics - Clinical Applications

Volumn 4, Issue 4, 2010, Pages 362-371

  Rodríguez Suárez, Eva ^a   Duce, Antonio M ^b   Caballería, Juan ^c   Arrieta, Félix Martínez ^d   Fern, Estefanía ^a   Gómara, Carolina ^a   Alkorta, Nere ^a   Ariz, Usue ^a   Martínez Chantar, M Luz ^a   Lu, Shelly C ^e   Elortza, Felix ^a   Mato, José M ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

DIGE; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Steatosis

Indexed keywords

CARBAMOYL PHOSPHATE SYNTHASE (GLUTAMINE HYDROLYSING); GLUCOSE REGULATED PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONALCOHOLIC FATTY LIVER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; WESTERN BLOTTING;

EID: 77953766314     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900119     Document Type: Article

References (48)

1. Matteoni, C. A., Younossi, Z. M., Gramlich, T., Boparai, N. et al., Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116, 1413-1419.
2. Reid, A. E., Nonalcoholic Steatohepatitis. Gastroenterology 2001, 121, 710-723.
3. Clark, J. M., Diehl, A. M., Hepatic steatosis and type 2 diabetes mellitus. Curr. Diab. Rep. 2002, 2, 210-215.
4. Marchesini, G., Bugianesi, E., Forlani, G., Cerelli, F. et al., Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37, 917-923.
5. Adams, L. A., Lindor, K. D., Nonalcoholic fatty liver disease. Ann. Epidemiol. 2007, 17, 863-869.
6. Angulo, P., Obesity and nonalcoholic fatty liver disease. Nutr. Rev. 2007, 65, S57-S63.
7. Younossi, Z. M., Baranova, A., Ziegler, K., Del Giacco, L. et al., A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology 2005, 42, 665-674.
8. Rubio, A., Guruceaga, E., Vázquez-Chantada, M., Sandoval, J. et al., Identification of a gene pathway associated with non-alcoholic steatohepatitis. J. Hepatol. 2007, 46, 708-718.
9. Charlton, M., Viker, K., Krishnan, A., Sanderson, S. et al., Differential expression of lumican and fatty acid binding protein-1: New insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology 2009, 49, 1375-1384.
10. Poordad, F. F., FIBROSpect II: a potential noninvasive test to assess hepatic fibrosis. Exp. Rev. Mol. Diagn. 2004, 4, 593-597.
11. Imbert-Bismut, F., Ratziu, V., Pieroni, L., Charlotte, F. et al., Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001, 357, 1069-1075.
12. Sandrin, L., Fourquet, B., Hasquenoph, J. M., Yon, S. et al., Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 2003, 29, 1705-1713.
13. Vanderschaeghe, D., Laroy, W., Sablon, E., Halfon, P. et al., GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol. Cell. Proteomics 2009, 8, 986-994.
14. Rabilloud, T., Two-dimensional gel electrophoresis in proteomics: old fashioned, but still climbs up mountains. Proteomics 2002, 2, 3-10.
15. Bengston, S., Krogh, M., Szigyarto, C. A., Uhlen, M. et al., Large-Scale proteomics analysis of human ovarian cancer for biomarkers. J. Proteome Res. 2007, 6, 1440-1450.
16. Douette, P., Navet, R., Gerkens, P., de Puw, E. et al., Steatosis-induced proteomic changes in liver mitochondria evidenced by two-dimensional differential in-gel electrophoresis. J. Proteome Res. 2005, 4, 2024-2031.
17. Zeindl-Eberhart, E., Haraida, S., Liebmann, S., Jungblut, P. R. et al., Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas. Hepatology 2004, 39, 540-549.
18. Ding, S. J., Li, Y., Zhou, H., Zeng, R. et al., Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 2004, 4, 982-994.
19. Yokoyama, Y., Terai, S., Ishilkawa, T., Aoyama, K. et al., Proteomic analysis of serum marker proteins in recipient mice with liver cirrhosis after bone marrow cell transplantation. Proteomics 2006, 6, 2564-2570.
20. Sun, W., Xing, B., Du, X., Lu, M. et al., Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis. Mol. Cell. Proteomics 2007, 10, 1798-1808.
21. Meneses-Lorente, G., Watt, A., Salim, K., Gaskell, S. J. et al., Identification of early proteomics markers for hepatic steatosis. Chem. Res. Toxicol. 2006, 19, 986-998.
22. Santamaría, E., Avila, M. A., Latasa, U., Rubio, A. et al., Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc. Natl. Acad. Sci. USA 2003, 100, 3065-3070.
23. Mölleken, C., Sitek, B., Henkel, C., Poschmann, G. et al., Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology 2009, 49, 1257-1266.
24. Meneses-Lorente, G., Guest, P. C., Lawrence, J., Muniappa, N. et al., A proteomic investigation of drug-induced steatosis in rat liver. Chem. Res. Toxicol. 2004, 17, 605-612.
25. Lee, I. N., Chen, C. H., Sheu, J. C., Lee, H. S. et al., Identification of human hepatocellular carcinoma-related biomarkers by two dimensional difference gel electrophoresis and mass spectrometry. J. Proteome Res. 2005, 4, 2062-2069.
26. Santamaría, E., Muñoz, J., Fernández-Irigoyen, J., Sesma, L. et al., Molecular profiling of hepatocellular carcinoma in mice with a chronic deficiency of hepatic S-adenosylmethionine: relevant in human liver diseases. J. Proteome Res. 2006, 5, 944-953.
27. Luk, J. M., Lam, C. T., Siu, A. F. M., Lam, B. Y. et al., Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, HSp70, GRP78) up-regulation and their associated prognostic values. Proteomics 2006, 6, 1049-1057.
28. Chignard, N., Shang, S., Wang, H., Marrero, J. et al., Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. Gastroenterology 2006, 130, 2010-2022.
29. Solga, S. F., Alkhuraishe, A., Cope, K., Tabesh, A. et al., Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations. Biomarkers 2006, 11, 174-183.
30. Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E. et al., Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004, 1, 185-194.
31. Feldstein, A. E., Canbay, A., Guicciardi, M. E., Higuchi, H. et al., Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J. Hepatol. 2003, 39, 978-983.
32. Ratziu, V., Giral, P., Charlotte, F., Bruckert, E. et al., Liver fibrosis in overweight patients. Gastroenterology 2000, 118, 1117-1123.
33. Alban, A., David, S. O., Bjorkesten, L., Andresson, C. et al., A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003, 3, 36-44.
34. Gharbi, S., Gaffney, P., Yang, A., Zvelebil, M. J. et al., Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell. Proteomics 2002, 1, 91-98.
35. Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A. et al., Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterology 1999, 94, 2467-2474.
36. Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C. et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41, 1313-1321.
37. Zeindl-Eberhart, E., Klugbaer, S., Dimitrijevic, N., Junbut, P. R. et al., Proteome analysis of rat hepatomas: carcinogendependent tumor associated protein variants. Electrophoresis 2001, 22, 3009-3018.
38. Leónard, J. F., Courcol, M., Mariet, C., Charbonnier, A. et al., Proteomic expression of the effects of clorofibrate on protein expression in rat liver. Proteomics 2006, 6, 1915-1933.
39. Feldstein, A. E., Wieckowska, A., lopez, A. R., Liu, Y. C. et al., Cytokeratin-18 fragment levels as noninvasive biomarker for nonalcoholic steatohepatitis: A multicenter validation study. Hepatology 2009, 50, 1072-1078.
40. West-Nielsen, M., Hogdall, E. V., Marchiori, E., Hogdall, C. K. et al., Sample handling for Mass Spectrometric proteomic investigations of human sera. Anal. Chem. 2005, 77, 5114-5123.
41. Petrak, J., Ivanek, R., Toman, O. m., Cmejla, R. et al., Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 2008, 8, 1744-1749.
42. Pyrko, P., Schö nthal, A. H., Hofman, F. M., Chen, T. C. et al., Glioma in humans is associated with upregulation of human GRP78 [HSPA5] protein in glioma. Cancer Res. 2007, 15, 67:9809-67:9816.
43. Antony, J. M., Ellestad, K. K., Hammond, R., Imaizumi, K. et al., Multiple sclerosis in humans is associated with upregulation of human BIP [HSPA5] protein in brain. J. Immunol. 2007, 15, 179:1210-179:1224.
44. Wieckowska, A., Zein, N. N., Yerian, L. M., Lopez, R. et al., In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006, 44, 27-33.
45. Poynard, T., Ratziu, V., Charlotte, F., Messous, D. et al., Diagnostic value of biochemical biomarkers (Nash Test) for the prediction of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006, 6, 34.
46. Neuschwander-Tetri, B. A., Fatty liver and the metabolic syndrome. Curr. Opin. Gastroenterol. 2007, 23, 193-198
47. Nakatani, Y., Kaneto, H., Kawamori, D., Yoshiuchi, K. et al., Involvement of endoplasmin reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 2005, 280, 847-851.
48. Ozcan, U., Cao, Q., Yimaz, E., Lee, A. H. et al., Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306, 457-461.